Interventions for melanoma in situ, including lentigo maligna (Q24202030)

2

0 references

Athanassios Kyrgidis

3

0 references

Simone Mocellin

4

0 references

An-Wen Chan

5

0 references

Shaheen Haque Hussain

6

0 references

Pierluigi Pilati

Cochrane Database of Systematic Reviews

7

0 references

publication date

31 January 2013

0 references

published in

0 references

cites work

Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

The Melanoma Epidemic: Res Ipsa Loquitur

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Dermatoscopy of lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Lentigo maligna and lentigo maligna melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Viral and nonviral uses of imiquimod: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Surgical treatment of lentigo maligna and lentigo maligna melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Imiquimod, a Toll-like receptor 7 agonist, inhibits melanogenesis and proliferation of human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Clinical application of multiphoton tomography in combination with confocal laser scanning microscopy for in vivo evaluation of skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Surgical margins for melanoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Carbon dioxide laser treatment for lentigo maligna: a retrospective review comparing 3 different treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Topical chemotherapy of lentigo maligna with 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Lentigo maligna--outcomes of treatment with Q-switched Nd:YAG and alexandrite lasers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Cutaneous melanoma in situ: translational evidence from a large population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Imiquimod in the treatment of lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Treatment of lentigo maligna with azelaic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

A role for topical 5-fluorouracil therapy in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Lentigo Maligna of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Lentigo maligna : prognosis and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Treatment of lentigo maligna with the carbon dioxide laser

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Sensitivity of pigmented mucosa and skin to freezing injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Cryosurgery for lentigo maligna

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

The biologic forms of malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Reliability of diagnosis of melanoma in situ

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Cryosurgery for lentigo maligna

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Mohs micrographic surgery for the treatment of primary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Mohs micrographic surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Inhibition of DNA synthesis of melanoma cells by azelaic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Cryotherapy for lentigo maligna

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Treatment of lentigo maligna

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Treatment of lentigo maligna and lentigo maligna melanoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

Surgical management of melanoma in situ on chronically sun-damaged skin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010308

7 January 2021

10.1002/14651858.CD010308

Identifiers

DOI

0 references

Fatcat ID

release_w24glkztuzaibljvae474yzaty

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w24glkztuzaibljvae474yzaty

24 November 2022